The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
Abstract
Myocardial infarction is the most frequent cause of mortality in the United States as well as in most western countries. In this review, the processes leading to myocardial infarction are described based on the most recent studies of vascular biology; in addition, evolving strategies for prevention are outlined. The following was specifically discussed. (1) Five phases of the progression of coronary atherosclerosis (phases 1 to 5) and eight morphologically different lesions (types I, II, III, IV, Va, Vb, Vc, and VI) in the various phases are defined. (2) The present understanding of the pathogenesis of each of the phases of progression and of the various lesion types preceding myocardial infarction is described; particular emphasis is placed on the physical, structural, cellular, and chemical characteristics of the "vulnerable or unstable plaques" prone to disruption (types IV and Va lesions). (3) The fate of plaque disruption (type VI lesion) in the genesis of the various coronary syndromes and especially acute myocardial infarction is defined; particular emphasis is placed on the combination of plaque disruption and a high thrombogenic risk profile--local factors (ie, degree of plaque disruption, exposure of lipid-macrophage-rich plaque, etc) and systemic factors (ie, catecholamines, RAS, fibrinogen, etc)--in the genesis of myocardial infarction. (4) Strategies of regression or stabilization of "vulnerable or unstable plaques" for prevention of myocardial infarction are presented within the context of recent favorable experience with risk factor modification and lipid-modifying angiographic trials, beta-blockade and angiotensin-converting enzyme inhibition, antithrombotic strategies, and the possible role of estrogens. The recent past has been very fruitful in yielding a better understanding of the processes leading to myocardial infarction, and the near future appears very promising in terms of preventing the number 1 killer in the western world.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, therapies for lowering the concentration of homocysteine through vitamin supplementation did not result in the suppression of events292, 293).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [293]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. I., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,716
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,786
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimón, L., Badimón, L., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,792
Self-citation(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Flagged first, then by citations
Cited by
Sorted by citations
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Self-citationMolecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygard, O. K., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,746
Atherosclerosis: Basic Mechanisms
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,730
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,288
Our Preoccupation With Coronary Luminology
Topol, E. J., & Nissen, S. E. (1995) · Circulation · doi:10.1161/01.cir.92.8.2333 · Cited by 1,112
Wexler, L., Brundage, B. H., Crouse, J. R., Detrano, R., Fuster, V., Maddahi, J., Rumberger, J. A., Stanford, W. L., White, R. D., & Taubert, K. A. (1996) · Circulation · doi:10.1161/01.cir.94.5.1175 · Cited by 1,068
Self-citationWhich White Blood Cell Subtypes Predict Increased Cardiovascular Risk?
Horne, B. D., Anderson, J. L., John, J. M., Weaver, A. N., Bair, T. L., Jensen, K. R., Renlund, D. G., & Muhlestein, J. B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.054 · Cited by 973
Greenland, P., Bonow, R. O., Brundage, B. H., Budoff, M. J., Eisenberg, M. J., Grundy, S. M., Lauer, M. S., Post, W. S., Raggi, P., Redberg, R. F., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.001 · Cited by 964
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
Bertrand, M. E. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3385 · Cited by 909
Shaw, L. J., Raggi, P., Schisterman, E. F., Berman, D. S., & Callister, T. Q. (2003) · Radiology · doi:10.1148/radiol.2283021006 · Cited by 884
Kornowski, R., Hong, M. K., Tio, F. O., Bramwell, O., Wu, H., & Leon, M. B. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00450-6 · Cited by 842
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
Dzau, V. J., Braun-Dullaeus, R. C., & Sedding, D. (2002) · Nature Medicine · doi:10.1038/nm1102-1249 · Cited by 840
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
O’Rourke, R. A., Brundage, B. H., Froelicher, V. F., Greenland, P., Grundy, S. M., Hachamovitch, R., Pohost, G. M., Shaw, L. J., Weintraub, W. S., Winters, W. L., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00831-7 · Cited by 790
Triggering Myocardial Infarction by Marijuana
Mittleman, M. A., Lewis, R. A., Maclure, M., Sherwood, J. B., & Muller, J. E. (2001) · Circulation · doi:10.1161/01.cir.103.23.2805 · Cited by 767
Prediction of coronary events with electron beam computed tomography
Arad, Y., Spadaro, L. A., Goodman, K., Newstein, D., & Guerci, A. D. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00872-x · Cited by 744
Atherothrombosis and High-Risk Plaque
Fuster, V., Moreno, P., Fayad, Z. A., Corti, R., & Badimón, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.074 · Cited by 757
Self-citationSimoons, M. L. (1996) · RePub (Erasmus University Rotterdam) · Cited by 706
Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography
Tearney, G. J., Yabushita, H., Houser, S. L., Aretz, H. T., Jang, I., Schlendorf, K. H., Kauffman, C. R., Shishkov, M. S., Halpern, E. F., & Bouma, B. E. (2003) · Circulation · doi:10.1161/01.cir.0000044384.41037.43 · Cited by 703
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 683
Toussaint, J., LaMuraglia, G. M., Southern, J. F., Fuster, V., & Kantor, H. L. (1996) · Circulation · doi:10.1161/01.cir.94.5.932 · Cited by 669
Self-citationA Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
The GUSTO-I Investigators (1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351103 · Cited by 655
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 596
Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction
Maddox, T. M., Stanislawski, M. A., Grunwald, G. K., Bradley, S. M., Ho, P. M., Tsai, T. T., Patel, M. R., Sandhu, A., Valle, J. A., Magid, D. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.14681 · Cited by 575
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
Yahagi, K., Kolodgie, F. D., Otsuka, F., Finn, A. V., Davis, H. R., Joner, M., & Virmani, R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.164 · Cited by 548
Meta-Analysis of the Morning Excess of Acute Myocardial Infarction and Sudden Cardiac Death
Cohen, M. C., Rohtla, K. M., Lavery, C. E., Muller, J. E., & Mittleman, M. A. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00181-1 · Cited by 535
Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque
Fayad, Z. A., & Fuster, V. (2001) · Circulation Research · doi:10.1161/hh1601.095596 · Cited by 519
Self-citationMiettinen, T. A., Pyörälä, K., Olsson, A. G., Musliner, T. A., Cook, T. J., Faergeman, O., Berg, K., Pedersen, T., Kjekshus, J., & Group, F. T. S. S. S. (1997) · Circulation · doi:10.1161/01.cir.96.12.4211 · Cited by 508
Mach, F., Schönbeck, U., Bonnefoy, J., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
Spencer, F. A., Goldberg, R. J., Becker, R. C., & Gore, J. M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00098-9 · Cited by 485
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 426
von Känel, R., Mills, P. J., Fainman, C., & Dimsdale, J. E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00003 · Cited by 422
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease
Austin, R. C., Lentz, S. R., & Werstuck, G. H. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401451 · Cited by 420
Ömürlü, İ. K., Türe, M., & Kurum, A. T. (2006) · Expert Systems with Applications · doi:10.1016/j.eswa.2006.09.004 · Cited by 406
Bertrand, M. E. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2301 · Cited by 412
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386
The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
Rudijanto, A. (2007) · PubMed · Cited by 378
Rasmussen, S. E., Frederiksen, H. W., Krogholm, K. S., & Bredsdorff, L. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400082 · Cited by 373
Myoishi, M., Hao, H., Minamino, T., Watanabe, K., Nishihira, K., Hatakeyama, K., Asada, Y., Okada, K.-I., Ishibashi‐Ueda, H., Gabbiani, G., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.682054 · Cited by 370
Circulating markers of inflammation and atherosclerosis
Lind, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00012-1 · Cited by 373
Théroux, P., & Fuster, V. (1998) · Circulation · doi:10.1161/01.cir.97.12.1195 · Cited by 355
Self-citationMacrophages, Smooth Muscle Cells, and Tissue Factor in Unstable Angina
Moreno, P., Bernardi, V., López-Cuellar, J., Murcia, A. M., Palacios, I. F., Gold, H. K., Mehran, R., Sharma, S. K., Nemerson, Y., Fuster, V., et al. (1996) · Circulation · doi:10.1161/01.cir.94.12.3090 · Cited by 355
Self-citationCoronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions
Wang, J. C., Normand, S. T., Mauri, L., & Kuntz, R. E. (2004) · Circulation · doi:10.1161/01.cir.0000135468.67850.f4 · Cited by 351
Lee, C.-D. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.8.758 · Cited by 346
Allograft Vasculopathy Versus Atherosclerosis
Rahmani, M., Cruz, R. P., Granville, D. J., & McManus, B. M. (2006) · Circulation Research · doi:10.1161/01.res.0000246086.93555.f3 · Cited by 346
LaMonte, M. J., FitzGerald, S. J., Church, T. S., Barlow, C. E., Radford, N. B., Levine, B. D., Pippin, J. J., Gibbons, L. W., Blair, S. N., & Nichaman, M. Z. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi228 · Cited by 340
Pasterkamp, G., Schoneveld, A. H., van der Wal, A. C., Haudenschild, C. C., Clarijs, R., Becker, A. E., Hillen, B., & Borst, C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00304-0 · Cited by 339
Inflammation in Peripheral Artery Disease
Brevetti, G., Giugliano, G., Brevetti, L., & Hiatt, W. R. (2010) · Circulation · doi:10.1161/circulationaha.109.918417 · Cited by 323
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Feasibility of FDG Imaging of the Coronary Arteries
Rogers, I. S., Nasir, K., Figueroa, A. L., Cury, R. C., Hoffmann, U., Vermylen, D., Brady, T. J., & Tawakol, A. A. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.01.004 · Cited by 304
Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences
Rauch, U., Osende, J. I., Fuster, V., Badimón, J. J., Fayad, Z. A., & Chesebro, J. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00014 · Cited by 300
Self-citationZhou, J., Lhoták, Š., Hilditch, B. A., & Austin, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160864.31351.c1 · Cited by 290
Sinha, M. K. (2004) · Emergency Medicine Journal · doi:10.1136/emj.2003.006007 · Cited by 285
de Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 283
Acute coronary syndromes: biology
Fuster, V., Fayad, Z. A., & Badimon, J. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90234-9 · Cited by 281
Self-citationMann, J. M., & Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.5.928 · Cited by 281
The role of plaque rupture and thrombosis in coronary artery disease
Zaman, A., Helft, G., Worthley, S. G., & Badimón, J. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00479-7 · Cited by 278
Circumferential Stress and Matrix Metalloproteinase 1 in Human Coronary Atherosclerosis
Lee, R. T., Schöen, F. J., Loree, H. M., Lark, M. W., & Libby, P. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.8.1070 · Cited by 278
Tea flavonoids and cardiovascular diseases: A review
Tijburg, L. B. M., Mattern, T., Folts, J. D., Weisgerber, U. M., & Katan, M. (1997) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399709527802 · Cited by 274
Feasibility of 18F-Sodium Fluoride PET/CT for Imaging of Atherosclerotic Plaque
Derlin, T., Richter, U., Bannas, P., Begemann, P. G. C., Buchert, R., Mester, J., & Klutmann, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076471 · Cited by 260
Yeghiazarians, Y., Braunstein, J. B., Askari, A. T., & Stone, P. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420207 · Cited by 255
Toward a New Frontier in Myocardial Reperfusion Therapy
Topol, E. J. (1998) · Circulation · doi:10.1161/01.cir.97.2.211 · Cited by 251
Clinical Pharmacology of Eptifibatide
Phillips, D. R., & Scarborough, R. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00572-9 · Cited by 250
Platelet Glycoprotein IIb/IIIa Antagonists
Scarborough, R. M., Kleiman, N. S., & Phillips, D. R. (1999) · Circulation · doi:10.1161/01.cir.100.4.437 · Cited by 246
THE VASCULAR BIOLOGY OF NITRIC OXIDE AND ITS ROLE IN ATHEROGENESIS
Lloyd‐Jones, D. M., & Bloch, K. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.365 · Cited by 243
Brown, D. W., Giles, W. H., & Croft, J. B. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00296-1 · Cited by 241
de Lorgeril, M., Salen, P., Martin, J., MAMELLE, N., Monjaud, I., Touboul, P., & Delaye, J. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00280-x · Cited by 228
Tahara, N., Kai, H., Yamagishi, S., Mizoguchi, M., Nakaura, H., Ishibashi, M., Kaida, H., Baba, K., Hayabuchi, N., & Imaizumi, T. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.046 · Cited by 224
Libby, P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01339-4 · Cited by 218
Tong, P. C. Y., Lee, K.-F., So, W., Ng, M. H. L., Chan, W. B., Lo, M. K. W., Chan, N. N., & Chan, J. C. N. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.216 · Cited by 215
White blood cells as a novel mortality predictor in haemodialysis patients
Reddan, D. N., Klassen, P., Szczech, L. A. M., Coladonato, J. A., O’Shea, S., Owen, W. F., & Lowrie, E. G. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg066 · Cited by 214
Madamanchi, N. R., Hakim, Z. S., & Runge, M. S. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01085.x · Cited by 216
Greniér, P., & Beigelman‐Aubry, C. (1998) · Thorax · doi:10.1136/thx.53.2008.s25 · Cited by 210
Risk Factors for Ischaemic Stroke
Allen, C., & Bayraktutan, U. (2008) · International Journal of Stroke · doi:10.1111/j.1747-4949.2008.00187.x · Cited by 212
C-REACTIVE PROTEIN, INFLAMMATION, AND CORONARY RISK
Morrow, D. A., & Ridker, P. M. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70211-x · Cited by 216
Hossain, G. S., van Thienen, J. V., Werstuck, G. H., Zhou, J., Sood, S. K., Dickhout, J. G., de Koning, A. B. L., Tang, D., Wu, D., Falk, E., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212897200 · Cited by 209
Platelets synthesize large amounts of active plasminogen activator inhibitor 1
Brogren, H., Karlsson, L., Andersson, M., Wang, L., Erlinge, D., & Jern, S. (2004) · Blood · doi:10.1182/blood-2004-04-1439 · Cited by 210
Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice
Eitzman, D. T., Westrick, R. J., Nabel, E. G., & Ginsburg, D. (2000) · Blood · doi:10.1182/blood.v95.2.577 · Cited by 202
Regulation of Arterial Thrombolysis by Plasminogen Activator Inhibitor-1 in Mice
Farrehi, P. M., Ozaki, C. K., Carmeliet, P., & Fay, W. P. (1998) · Circulation · doi:10.1161/01.cir.97.10.1002 · Cited by 200
Unanswered Questions for Management of Acute Coronary Syndrome
Bugiardini, R., Manfrini, O., & Ferrari, G. M. D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1391 · Cited by 200
Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients
Halle, A. A., DiSciascio, G., Massin, E. K., Wilson, R. F., Johnson, M. R., Sullivan, H. J., Bourge, R. C., Kleiman, N. S., Miller, L. W., Aversano, T. R., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00124-i · Cited by 197
Computation of hemodynamics in the left coronary artery with variable angulations
Chaichana, T., Sun, Z., & Jewkes, J. W. (2011) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2011.04.033 · Cited by 192
Coronary Artery Calcium in Acute Coronary Syndromes
Schmermund, A., Baumgart, D., Görge, G., Seibel, R. M. M., Grönemeyer, D. H. W., Ge, J., Haude, M., Rumberger, J. A., & Erbel, R. M. (1997) · Circulation · doi:10.1161/01.cir.96.5.1461 · Cited by 192
Ultrasound and Lipoproteins as Predictors of Lipid-Rich, Rupture-Prone Plaques in the Carotid Artery
Grønholdt, M.-L. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.2 · Cited by 190
Schrör, K. (1995) · Drugs · doi:10.2165/00003495-199550010-00002 · Cited by 189
Subclinical atherosclerosis: what it is, what it means and what we can do about it
Toth, P. P. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01804.x · Cited by 201
C-reactive protein, inflammation, and coronary risk
Ridker, P. M., & Morrow, D. A. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00079-1 · Cited by 192
Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors
Fuster, V., Gotto, A. M., Libby, P., Loscalzo, J., & McGill, H. C. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00014-9 · Cited by 190
Self-citationGianaros, P. J., & Sheu, L. K. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.073 · Cited by 185
White Blood Cell Count and the Risk of Coronary Heart Disease and All-Cause Mortality in Elderly Men
Weijenberg, M. P., Feskens, E. J. M., & Kromhout, D. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.4.499 · Cited by 178
Anand, M., Rajagopal, K., & Rajagopal, K. R. (2003) · Computational and Mathematical Methods in Medicine · doi:10.1080/10273660412331317415 · Cited by 172
Munday, J. S., Thompson, K. G., & James, K. A. C. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599000458 · Cited by 175
Development and Disease in Proteinase-Deficient Mice
Carmeliet, P., & Collen, D. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00122-4 · Cited by 174
Blood‐induced joint damage: A canine in vivo study
Roosendaal, G., TeKoppele, J. M., Vianen, M. E., van den Berg, H. M., Lafeber, F. P. J. G., & Bijlsma, J. W. J. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5 · Cited by 137
Pathogenetic concepts of acute coronary syndromes
Corti, R., Fuster, V., & Badimón, J. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02833-4 · Cited by 168
Self-citationChen, X. Y., Wong, K. S., Lam, W. W. M., Zhao, H.-L., & Ng, H. (2007) · Cerebrovascular Diseases · doi:10.1159/000111525 · Cited by 167
Metadata
- Authors
- Fuster, V
- Affiliations
- Mount Sinai Hospital (US)
- Corresponding author
- Fuster, V
- ORCID
- Fuster, V
- Venue
- Circulation
- Published
- 1994-10
- Volume
- 90
- Issue
- 4
- Pages
- 2126-2146
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2110185147
- Cited by
- 848
- References
- 240
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 4 · 2020: 14 · 2019: 6 · 2018: 5 · 2017: 12 · 2016: 19 · 2015: 16 · 2014: 19 · 2013: 24 · 2012: 18
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- myocardial infarction, coronary artery disease, vulnerable plaque, plaque disruption, lesion type, plaque regression, thrombosis, coronary syndrome, risk factor control, lipid therapy, beta-adrenergic blockade, angiotensin-converting enzyme inhibition, antithrombotic therapy, estrogen, vascular biology
- MeSH terms
- Coronary Artery Disease, Coronary Thrombosis, Coronary Vessels, Humans, Myocardial Infarction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review